Platelet factor 4 release in patients undergoing cardiopulmonary resuscitation - Can reperfusion be impaired by platelet activation?

Acta Anaesthesiologica Scandinavica

Volumn 40, Issue 5, 1996, Pages 631-635

  Bottiger B W ^a   Bohrer H ^a   Boker T ^a   Motsch, J ^a   Aulmann, M ^a   Martin, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; No reflow phenomenon; Platelet factor 4; Reperfusion

Indexed keywords

THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ARREST; HUMAN; MALE; MICROCIRCULATION; PRIORITY JOURNAL; REPERFUSION INJURY; RESUSCITATION; THROMBOCYTE ACTIVATION;

EID: 0029944267     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1996.tb04499.x     Document Type: Article

References (31)

1. Böttiger BW, Motsch J, Böhrer H, Böker T, Aulmann M, Nawroth PP, Martin E. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis Circulation 1995: 92: 2572-2578.
2. Hartveit F, Halleraker B. Intravascular changes in kidneys and lungs after external cardiac massage: A preliminary report. J Pathol 1970: 102: 54-58.
3. Hekmatpanah J. Cerebral blood flow dynamics in hypotension and cardiac arrest. Neurology 1973: 23: 174-180.
4. Ames A III, Wright RL, Kowada M, Thurston JM, Wagno G. Cerebral ischemia II. The no-reflow phenomenon. Am J Pathol 1968: 52: 437-453.
5. Fischer EG, Ames A. Studies on mechanisms of impairment of cerebral circulation following ischemia: Effect of hemodilution and perfusion pressure. Stroke 1972: 3: 538-542.
6. Fischer M, Hossmann KA. No-reflow after cardiac arrest. Intensive Care Med 1995: 21: 132-141.
7. Crowell JW, Sharpe GP, Lambright RL, Read WL. The mechanism of death after resuscitation following acute circulatory failure. Surgery 1955: 38: 696-702.
8. Crowell JW, Smith EE. Effect of fibrinolytic activation on survival and cerebral demage following periods of circulatory arrest. Am J Physiol 1956: 186: 283-285.
9. Safar P, Stezoski SW, Nemoto EM. Amelioration of brain damage after 12 minutes cardiac arrest in dogs. Arch Neurol 1976: 33: 91-95.
10. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA. Thrombolysis with rt-PA reduced cerebral no-reflow after resuscitation from cardiac arrest. Anesthesiology 1994: 81[3A]: A858.
11. Böttiger BW, Böhrer H, Bach A, Motsch J, Martin E. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 1994: 28: 45-54.
12. Gramann J, Lange-Braun P, Bodemann T, Hochrein H. Einsatzmöglichkeiten der Thrombolyse in der Reanimation. Intensivmed 1988: 25: 425-429.
13. Rosenfeld BA, Faraday N, Campbell D, Dise K, Bell W, Goldschmidt P. Hemostatic effects of stress hormone infusion. Anesthesiology 1994: 81: 1116-1126.
14. Zucker MB, Katz IR. Platelet factor 4: production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med 1991: 198: 693-702.
15. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett PJ, Becker L, et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: The Utstein Style. Circulation 1991: 84: 960-975.
16. Contant G, Gouault-Heilmann M, Martinoli JL. Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole - C.T.A.D mixture. Thromb Res 1983: 31: 365-374.
17. Kaplan KL, Owen J. Plasma levels of β-rhromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981: 57: 199-202.
18. Rotmensch HH, Vlasses PH, Carpenter KL, D'Amelio LF, Swanson BN, Ferguson RK. Plasma platelet products and exercise-induced myocardial ischemia. J Lab Clin Med 1983: 102: 63-69.
19. Minar E, Ehringer H. Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Thromb Res 1987: 45: 791-802.
20. Gaszynski W. Research work on blood clotting system during cardiopulmonary resuscitation. Anaesth Resus Inten Therap 1974: 2: 303-316.
21. D'Andrea G, Joseph R, Cananzi AR, Ferro-Milone F, Grünfeld S, Toldo M, Welch MA. Platelet alpha granula secretion in cerebral ischemia: effect of short and long term low dose aspirin treatment. Funct Neurol 1988: 3: 179-185.
22. Levine SP, Lindenfeld J, Ellis JB, Rayamond NM, Krentz LS. Increased plasma concentration of platelet factor 4 in coronary artery disease. A measure of in vivo platelet activation and secretion. Circulation 1981: 64: 626-632.
23. Yamauchi K, Furui H, Taniguchi N, Sotobata I. Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn Heart J 1986: 27: 481-487.
24. Carr ME, White GC II, Gabriel DA. Platelet factor 4 enhances fibrin polymerization. Thromb Res 1987: 45: 539-543.
25. Huang S, Paulauskis JD, Godleski JJ, Kobzik L. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 1992: 141: 981-988.
26. Walz A, Dewald B, von Tscharner V, Baggiolini M. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 1989: 170: 1745-1750.
27. Sharpe RJ, Maione TE, Whitaker D, Murphy GF. Induction of intercellular adhesion molecule-1 (ICAM-1) in cultured endothelium by recombinant platelet factor 4 (PF-4). J Invest Dermatol 1990: 94: 578.
28. Bebawy ST, Gorka J, Hyers TM, Webster RO. In vitro effects of platelet factor 4 on normal human neutrophil functions. J Leucocyte Biol 1986: 39: 423-434.
29. Rybak ME, Gimbrone MA Jr, Davies PF, Handin RI. Interaction of platelet factor four with cultured vascular endothelial cells. Blood 1989: 73: 1534-1539.
30. Sharpe RJ, Murphy GF, Whitaker D, Galli SJ, Maione TE. Induction of local inflammation by recombinant human platelet factor 4 in the mouse. Cell Immunol 1991: 137: 72-80.
31. Tanahashi N, Fukuuchi Y, Tomita M, Kobari M, Shinohara T, Yamawaki T, et al. Platelet-activating factor antagonist (TCV-309) ameliorates postischemic delayed hypoperfusion after 30-s cardiac arrest in cats. In: Tomita M, Mchedlishvili G, Rosenblum W, Heiss WD, Fukuuchi Y eds. Microcirculatory stasis in the brain. Amsterdam - London - New York - Tokio: Excerpta medica, 1993: 203-210.